GSK announces Q2 results for 2010
Q2 EPS before major restructuring* 2.6p (29.3p excluding pre-announced legal charge)
Download GSK Q2 results 2010 as a PDF
For further details, videos and the analyst webcast, visit the Investors section of GSK.com.
- Careers |
- Media |
- Investors |
- Consumers |
- Healthcare professionals |
-
Select country
Asia & the Middle East
South & Central America
GSK around the world
Select a country to find out more about GSK around the world.
Home
Explore GSK
Health for all
All about our work fighting disease across the world
How we do R&D
Read the stories behind our R&D operations
Our communities
Stories about our many community projects around the world
Business strategy
Find out what our strategic priorities mean for our research, our people, our products and our partners
Everyday health
Find out things you didn't know about our everyday products
Our planet
Find out all about our approach to caring for the planet
Our people
Find out about what GSK people have been up to, including our local and overseas community volunteers
Our products
Find out about GlaxoSmithKline's products.
Research
Science & innovation
Find out how science and innovation underpin our R&D in vaccines, medicines and consumer healthcare.
Our product pipeline
A comprehensive list of all our vaccines, medicines and consumer healthcare products.
How we discover new medicines
Find out about the process behind the research and discovery of new medicines.
How we protect against disease
Find out how GlaxoSmithKline protects against disease.
Trials in people
Learn about how our clinical trials work, and also find out how to become a research volunteer yourself.
Fighting disease in the developing world
Find out how we research and develop new medicines that treat and prevent diseases of the developing world.
Our use of animals
Information on when and how we use animals for research, how we ensure their welfare and how we limit their use.
R&D locations
Find locations where GlaxoSmithKline carries out its R&D operations.
Careers in R&D
Find out more about career opportunities in GlaxoSmithKline R&D.
Partnerships
Why work with us
Information on what we can offer you as an alliance partner, from business development and contract services, to academic collaborations and investment.
Business development
We know that our alliance partners face unique challenges and opportunities. We work to understand these issues and design an approach to match.
Academic collaborations
Find out how we work with academic institutions and who to contact if you are interested in working with us.
Open innovation
Find out how we work with partners in R&D and share our expertise, intellectual property and facilities to discover new medicines.
Innovation and investment
Find out how we ensure we have a steady supply of great ideas and innovative science from both inside and outside the company.
Our manufacturing services
We provide contract manufacturing services in antibiotics, biopharmaceuticals and pharmaceuticals - find out more.
GSK McLaren partnership
Find out all about our partnership with McLaren Group.
Responsibility
Our behaviour
We strive to behave in an open and honest manner in all that we do – find out how we apply this to our business.
Our planet
Learn about our commitment to the environment including our targets to cut emission and waste, and improve efficiency.
Health for all
Find out how we are helping improve people’s health and well-being regardless of where they live or their ability to pay.
Our people
See how we work to support the development of our people around the world.
Products
Our prescription medicines
Our prescription medicines include treatments for a wide range of conditions such as infections, depression, skin conditions, asthma, heart and circulatory disease and cancer.
Our vaccines
We produce more than 30 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, and more.
Our consumer healthcare products
We bring dental health products, over-the-counter medicines and nutritional drinks to millions of people.
About us
What we do
An overview of what GSK does worldwide including information on our three main business areas: Pharmaceuticals, Vaccines and Consumer Healthcare
Key achievements
Find out about our key achievements since we became GlaxoSmithKline in 2001
Board of Directors
Find out who sits on GSK’s board of directors
Corporate Executive Team
Our Corporate Executive Team assists the CEO in managing the business – find out about its members
Our history
GSK was formed in 2000 when Glaxo Wellcome plc and SmithKline Beecham merged, but the combined histories of the two companies go back centuries. Find out more with our interactive timeline.
Governance
Information on the governance of GlaxoSmithKline, including details on the board committees, information for shareholders, and how we maintain our corporate ethics.
Contact us
Find contact details for GlaxoSmithKline's main corporate offices in the UK and US.
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.